These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32195970)
1. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report. Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970 [TBL] [Abstract][Full Text] [Related]
2. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours. Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619 [TBL] [Abstract][Full Text] [Related]
3. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor. Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942 [TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts. Qiu X; Montgomery E; Sun B Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall. Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695 [TBL] [Abstract][Full Text] [Related]
7. An inflammatory myofibroblastic tumour of the breast with ALK overexpression. Zhou Y; Zhu J; Zhang Y; Jiang J; Jia M BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23386486 [TBL] [Abstract][Full Text] [Related]
8. Inflammatory myofibroblastic tumor of the central nervous system: clinicopathologic analysis of 10 cases. Jeon YK; Chang KH; Suh YL; Jung HW; Park SH J Neuropathol Exp Neurol; 2005 Mar; 64(3):254-9. PubMed ID: 15804057 [TBL] [Abstract][Full Text] [Related]
10. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases]. Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263 [No Abstract] [Full Text] [Related]
11. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification. Wang K; Guo R; Siegal GP; Wei S Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196 [TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report. Liu Q; Wei J; Liu X; Wang J Medicine (Baltimore); 2019 Dec; 98(52):e18414. PubMed ID: 31876714 [TBL] [Abstract][Full Text] [Related]
13. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis. Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082 [TBL] [Abstract][Full Text] [Related]
14. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall. Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype. Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312 [TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-related markers in inflammatory myofibroblastic tumors of the head and neck. Wang KR; Jiang T; Wu TT; Zhou SH; Yao HT; Wang QY; Lu ZJ World J Surg Oncol; 2013 Nov; 11():294. PubMed ID: 24245510 [TBL] [Abstract][Full Text] [Related]
17. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases. Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797 [TBL] [Abstract][Full Text] [Related]
18. Inflammatory myofibroblastic tumors of the head and neck: evaluation of clinicopathologic and prognostic features. Devaney KO; Lafeir DJ; Triantafyllou A; Mendenhall WM; Woolgar JA; Rinaldo A; Ferlito A Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2461-5. PubMed ID: 22588194 [TBL] [Abstract][Full Text] [Related]
19. An isolated inflammatory myofibroblastic tumor of adrenal gland. Al Sannaa G; Wimmer JL; Ayala AG; Ro JY Ann Diagn Pathol; 2016 Dec; 25():33-36. PubMed ID: 27806843 [TBL] [Abstract][Full Text] [Related]
20. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations. Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]